UPDATE 1-Court rejects Sequenom bid to restore prenatal DNA test patent

NEW YORK, Dec 2 (Reuters) - A U.S. appeals court on Wednesday refused to reconsider a decision invalidating a Sequenom Inc prenatal DNA test patent, in a decision that could put in doubt the validity of a wide swath of medical and biotechnology patents.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.